| top | |
| BRAINLIFE NEWSLETTER | |
Volume 4, Supplement 3 - 13 April 2005 |
|
|
|
|
|
Low Grade Gliomas (1) |
|
|
|
|
|
Diagnosis |
|
|
De
Witte O, Oulad Ben Taib N, Branle F, Rorive S, Brotchi J, Goldman S Contribution of PET to the management of patients with low-grade glioma Neurochirurgie. 2004 Sep;50(4):468-73. (Clinical Study, Abstract) |
|
|
De
Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, Salmon I,
Brotchi J, Goldman S Positron emission tomography with injection of methionine as a prognostic factor in glioma J Neurosurg. 2001 Nov;95(5):746-50. (Clinical Study, Abstract) |
|
|
Mandonnet
E, Delattre JY, Tanguy ML, Swanson KR, Carpentier AF, Duffau H, Cornu
P, Van Effenterre R, Alvord EC Jr, Capelle L Continuous growth of mean tumor diameter in a subset of grade II gliomas Ann Neurol. 2003 Apr;53(4):524-8. (Clinical Study, Abstract) |
|
|
Marcus
Henze, MD, Ashour Mohammed, PhD, Heinz P. Schlemmer, MD, Klaus K.
Herfarth, MD, Simone Hoffner, MD, Sabine Haufe, MD, Walter Mier, PhD,
Michael Eisenhut, PhD, Jürgen Debus, MD, PhD and Uwe Haberkorn, MD
PET and SPECT for Detection of Tumor Progression in Irradiated Low-Grade Astrocytoma: A Receiver-Operating-Characteristic Analysis Journal of Nuclear Medicine, April 1 2004, Volume 45, Issue 4, Pages 579-586. (Clinical Study, Abstract) |
|
|
Herholz
K, Holzer T, Bauer B, Schroder R, Voges J, Ernestus RI, Mendoza G,
Weber-Luxenburger G, Lottgen J, Thiel A, Wienhard K, Heiss WD
11C-methionine PET for differential diagnosis of low-grade gliomas Neurology. 1998 May;50(5):1316-22. (Clinical Study, Abstract) |
|
|
Nuutinen
J, Sonninen P, Lehikoinen P, Sutinen E, Valavaara R, Eronen E,
Norrgard S, Kulmala J, Teras M, Minn H Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):43-52. (Clinical Study, Abstract) |
|
|
Pirzkall
A, Nelson SJ, McKnight TR, Takahashi MM, Li X, Graves EE, Verhey LJ,
Wara WW, Larson DA, Sneed PK Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1254-64. (Clinical Study, Abstract) |
|
|
Ribom
D, Larsson A, Pietras K, Smits A Growth factor analysis of low-grade glioma CSF: PDGF and VEGF are not detectable Neurol Sci. 2003 Jun;24(2):70-3. (Laboratory Investigation, Abstract) |
|
|
Ribom
D, Westman-Brinkmalm A, Smits A, Davidsson P Elevated levels of alpha-2-Heremans-Schmid glycoprotein in CSF of patients with low-grade gliomas Tumour Biol. 2003 Mar-Apr;24(2):94-9. (Laboratory Investigation, Abstract) |
|
|
Ribom
D, Engler H, Blomquist E, Smits A Potential significance of (11)C-methionine PET as a marker for the radiosensitivity of low-grade gliomas Eur J Nucl Med Mol Imaging. 2002 May;29(5):632-40. Epub 2002 Mar 5. |
|
|
Ribom
D, Eriksson A, Hartman M, Engler H, Nilsson A, Langstrom B, Bolander H,
Bergstrom M, Smits A Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas Cancer. 2001 Sep 15;92(6):1541-9. (Clinical Study, Abstract) |
|
|
|
|
|
Etiology & Pathogenesis |
|
|
|
|
|
Molecular Genetic Aspects of Oligodendrogliomas Including Analysis by Comparative Genomic Hybridization American Journal of Pathology. August 1999;155:375-386. (Laboratory Investigation, Abstract & PDF Full Text) |
|
|
JG Cairncross, K Ueki, MC Zlatescu, DK
Lisle, DM Finkelstein, RR Hammond, JS Silver, PC Stark, DR Macdonald, Y Ino,
DA Ramsay and DN Louis
Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas Journal Of The National Cancer Institute, Vol 90, 1473-1479; 7 October 1998. (Clinical Study, Abstract & PDF Full Text) |
|
| He
J, Mokhtari K, Sanson M, Marie Y, Kujas M, Huguet S, Leuraud P,
Capelle L, Delattre JY, Poirier J, Hoang-Xuan K
Glioblastomas with an oligodendroglial component: a pathological and molecular study J Neuropathol Exp Neurol. 2001 Sep;60(9):863-71. (Laboratory Investigation, Abstract) |
|
| He
J, Hoang-Xuan K, Marie Y, Leuraud P, Mokhtari K, Kujas M, Delattre JY,
Sanson M
P18 tumor suppressor gene and progression of oligodendrogliomas to anaplasia Neurology. 2000 Sep 26;55(6):867-9. (Laboratory Investigation, Abstract) |
|
|
Hoang-Xuan
K, He J, Huguet S, Mokhtari K, Marie Y, Kujas M, Leuraud P,
Capelle L, Delattre JY, Poirier J, Broet P, Sanson M Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression Neurology. 2001 Oct 9;57(7):1278-81. (Laboratory Investigation, Abstract) |
|
|
Laigle-Donadey
F, Martin-Duverneuil N, Lejeune J, Criniere E, Capelle L, Duffau H, Cornu P,
Broet P, Kujas M, Mokhtari K, Carpentier A, Sanson M, Hoang-Xuan K, Thillet J,
Delattre JY Correlations between molecular profile and radiologic pattern in oligodendroglial tumors Neurology. 2004 Dec 28;63(12):2360-2. (Laboratory Investigation, Abstract) |
|
|
Q. Richard Lu, John K. Park, Elizabeth Noll,
Jennifer A. Chan, John Alberta, Dongin Yuk, M. Garcia Alzamora, David N. Louis,
Charles D. Stiles, David H. Rowitch, and Peter M. Black
Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors PNAS, September 11, 2001, Vol. 98, No. 19, Pages 10851-10856. (Laboratory Investigation, Abstract & PDF Full Text) |
|
|
Marie
Y, Sanson M, Mokhtari K, Leuraud P, Kujas M, Delattre JY, Poirier J,
Zalc B, Hoang-Xuan K OLIG2 as a specific marker of oligodendroglial tumour cells Lancet. 2001 Jul 28;358(9278):298-300. (Laboratory Investigation, Abstract) |
|
|
Mokhtari
K, Paris S, Aguirre-Cruz L, Privat N, Criniere E, Marie Y, Hauw JJ,
Kujas M, Rowitch D, Hoang-Xuan K, Delattre JY, Sanson M
Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification Neuropathol Appl Neurobiol. 2005 Feb;31(1):62-9. (Laboratory Investigation, Abstract) |
|